Question 1

What is the catalog number for ZNF319 CRISPRa sgRNA lentivector (set of three targets)(Human)?

Accepted Answer

The catalog number for ZNF319 CRISPRa sgRNA lentivector (set of three targets)(Human) is 51437121.

Question 2

What sizes are available for ZNF319 CRISPRa sgRNA lentivector (set of three targets)(Human)?

Accepted Answer

ZNF319 CRISPRa sgRNA lentivector (set of three targets)(Human) is available in the following size(s): 3x 1.0µg DNA.

Question 3

Is ZNF319 CRISPRa sgRNA lentivector (set of three targets)(Human) in stock?

Accepted Answer

ZNF319 CRISPRa sgRNA lentivector (set of three targets)(Human) is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

What dilution range is recommended for immunohistochemistry (IHC) with this antibody?

Accepted Answer

A starting IHC dilution range is listed on the datasheet, but should be optimized for your specific tissue type and staining protocol.

Question 5

Can I request a Safety Data Sheet (SDS) for this product?

Accepted Answer

Yes, safety data sheets are available for hazardous or chemically classified products and can be provided on request or downloaded from the product page.

Question 6

Can this product be used for co-immunoprecipitation (Co-IP)?

Accepted Answer

Suitability for Co-IP depends on the specific antibody and is noted under validated applications on the datasheet. If it isn’t listed, contact our technical support team for guidance based on your target and sample type.

ZNF319 CRISPRa sgRNA lentivector (set of three targets)(Human)

Product Specifications

Gene Name

Gene Aliases

Accession Number

Reactivity

Vector Name

Shipping Conditions

Storage Conditions

Frequently Asked Questions

Explore Other Products

Anti-ZP2 Antibody Picoband®

Cytochrome C (CYCS/1010), CF640R conjugate, 0.1mg/mL

CD79a (IGA/1688R), CF640R conjugate, 0.1mg/mL

Anti-Phospho-Histone H2B (T129) HIST1H2BC Rabbit Monoclonal Antibody

Laminin (A5), CF543 conjugate, 0.1mg/mL

PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2743), 1mg/mL